Healthcare organizations deal with a constant stream of regulations, contractual requirements, operational decisions, audits, investigations, and changes in how care is delivered. With so many moving parts, one question comes up repeatedly for compliance professionals: When does an issue belong with compliance, and when does it require legal involvement? The answer depends heavily on the situation, the level of risk, and what the organization is trying to accomplish.

Medical billing and coding sits at the intersection of clinical care, documentation, reimbursement, payer requirements, credentialing, and compliance. Every claim represents a series of decisions about what service was provided, who provided it, where it was provided, how long it lasted, which code applies, and whether the payer has additional requirements that must be satisfied before payment.

What makes CRUSH particularly interesting is the breadth of who and what it could impact. This isn't just about DME fraud. The ideas CMS is considering potentially touch hospitals, laboratories, Medicare Advantage and Part D plans, Medicaid and CHIP, DMEPOS suppliers, provider enrollment, billing, AI, payment suspensions, ownership disclosure, beneficiary solicitation and more.

Private equity and other forms of outside investment have become an increasingly visible part of healthcare. Investment can bring capital, infrastructure, technology, and opportunities for growth, but it also creates compliance considerations that healthcare organizations need to address directly.

Understanding Where the Medicare Advantage Guidance Fits The new OIG Guidance In Medicare Advantage gives healthcare organizations a more focused framework for understanding and managing compliance risks within the Medicare Advantage sector. The Medicare Advantage Industry Segment-Specific Compliance Program Guidance, or ICPG, does not replace the OIG’s General Compliance Program Guidance or the seven elements of an effective compliance program; instead, it adds Medicare Adva

The Methodist settlement serves as a sobering reminder that EMTALA compliance is no longer judged solely by what happens in the treatment room. It is judged by the entire patient journey from the moment the individual arrives at the emergency department doors.

Healthcare organizations often enter new Medicaid initiatives with a strong understanding of regulatory requirements. The reality is that California healthcare compliance also depends on whether your operational model can consistently deliver the services those regulations are designed to support.

At first glance, the proposed 2027 Home Health Prospective Payment System rule appears to be a routine update. But buried within the proposed rule is something far more significant. Read more to understand the compliance implications.

California Medicaid, better known as Medi-Cal, is one of the largest and most sophisticated Medicaid programs in the country. Covering approximately 15 million beneficiaries across urban centers, rural communities, and everything in between, the program presents operational challenges that extend well beyond understanding regulations.

Provider directories are no longer simply member-facing tools. They are increasingly being viewed as evidence of network adequacy, access to care, and organizational accountability.

The recent $30 million settlement involving Advanced Pathology Solutions (APS) is being reported as another kickback case. While that's true, focusing only on the Anti-Kickback Statute misses the bigger compliance lesson.

An important reminder that clinical judgement cannot be delegated, automated, or subordinated to business objectives.

California Medicaid, known throughout the state as Medi-Cal, is one of the largest and most complex healthcare programs in the country. Serving millions of beneficiaries across diverse communities requires far more than administering healthcare benefits. It demands collaboration between health plans, providers, community organizations, government agencies, and compliance professionals who all play a role in ensuring patients receive timely, appropriate care.

Interest in GLP-1 medications has grown rapidly, and with that growth has come an increase in organizations offering prescriptions through online platforms. GLP-1 telehealth has created new opportunities for patients to access care, particularly for those who face transportation barriers or limited provider availability. The reality is that convenience should never come at the expense of patient safety, regulatory compliance, or sound clinical judgment.

Healthcare organizations are increasingly using technology to streamline referrals, improve care coordination, and reduce administrative burden. This article highlights how responsible compliance professionals must balance these benefits with how they influence referral patterns and financial relationships between parties.

California has adopted its first comprehensive hospice licensing regulations, which include a sweeping set of operational requirements that touch everything from staffing ratios and administrator qualifications to geographic service areas and response times. Here's why compliance professionals across the country should be paying attention.

The demand for GLP-1 medications continues to grow, and with that growth comes a new set of operational and regulatory challenges for healthcare organizations. While much of the public conversation centers on patient access and clinical outcomes, compliance professionals are spending more time evaluating the compliance concerns regarding GLP-1s that can affect prescribing practices, documentation, reimbursement, marketing, and organizational oversight.

When organizations talk about strengthening compliance, the conversation often begins with policies, training requirements, audits, and reporting structures. Those elements matter, but they are rarely what determines whether a compliance program succeeds or struggles. The reality is that compliance culture is built through relationships.

When healthcare organizations discuss compliance, the conversation often centers around regulations, policies, audits, and corrective action plans. Those elements are important, but compliance programs ultimately succeed or struggle based on something much more fundamental: trust. The reality is that employees are far more likely to raise concerns, ask questions, and report potential issues when they trust the people leading compliance efforts.

When people talk about compliance at a critical access hospital, the conversation often starts with limited resources. While resource constraints are certainly part of the reality, they only tell part of the story. What organizations often overlook is that critical access hospitals operate in environments where leaders frequently carry responsibility for multiple functions at the same time, creating both challenges and opportunities that larger healthcare systems may never ex